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New psychoactive substances (NPSs) have become increasingly popular in recent years. The analysis of
these substances in inﬂuent wastewater (IWW) can be used to track their use in communities. In ad-
dition, an evaluation of the amount of NPSs released to the aquatic environment can be performed
through the analysis of efﬂuent wastewater (EWW). This study presents the development, validation and
application of an analytical methodology, based on solid phase extraction (SPE) and liquid chromato-
graphy-tandem mass spectrometry (LC-MS/MS), for the determination of 10 NPSs in IWW and EWW.
Synthetic cannabinoids, cathinones, piperazines and pyrrolidophenones are included among the target
analytes. To the authors’ knowledge, it is the ﬁrst time that eight out of these substances (4’-methyl-
pyrrolidinobutyrophenone (MPPP), a-pyrrolidinopentiophenone (a-PVP), 2-[(1S,3R)-3-hydro-
xycyclohexyl]-5-(2-methyl-2-octanyl) phenol (CP47,497), (1-naphthyl(1-pentyl-1H-indol-3-yl) metha-
none (JWH-018), (1-butyl-1H-indol-3-yl)(1-naphthyl) methanone (JWH-073), (4-ethyl-1-naphthyl)(1-
pentyl-1H-indol-3-yl) methanone (JWH-210), (4-methyl-1-naphthyl) (1-pentyl-1H-indol-3-yl) metha-
none (JWH-122) and 2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl) ethanone (JWH-250)) are in-
vestigated in wastewater. The optimized conditions for the analysis of this set of compounds included a
SPE clean-up step using a polymeric sorbent and the use of a pentaﬂuorophenyl (PFP) chromatographic
column. Despite the broad range of physicochemical properties of the analytes the method allowed
acceptable absolute recoveries (40–109%) for all the studied compounds at different levels of con-
centration. Low method limits of detection (MLODs) were achieved, ranging between 0.3 and 10 ng/L
except for BZP and CP47,497 (20 and 23 ng/L, respectively), allowing a reliable and accurate quantiﬁ-
cation of the analytes. The method was successfully applied to the analysis of IWW and EWW samples
from ﬁve wastewater treatment plants (WWTPs) located in Santorini Island (a highly touristic resort in
Greece). Four out of 10 compounds (a-PVP, CP47,497, JWH-122 and JWH-210) were detected at least in
one sample, being the ﬁrst evidence of their presence in wastewater. CP47,497 was the most ubiquitous
and abundant compound, showing concentrations up to 634 ng/L in some cases.
& 2015 Elsevier B.V. All rights reserved.1. Introduction
In recent years, a high number of new substances, commonly
named as new psychoactive substances (NPSs), have been ap-
peared on the market. According to the deﬁnition provided by
EMCDDA, NPSs are new narcotic or psychotropic drugs, in pure
form or in preparation, that are not controlled by the 1961 United
Nations Single Convention on Narcotic Drugs or the 1971 United
Nations Convention on Psychotropic Substances, but which mays).pose a public health threat comparable to that posed by sub-
stances listed in these conventions (Council Decision 2005/387/
JHA) [1]. NPSs comprise a broad range of substances, including
synthetic cannabinoids, cathinones, piperazines, tryptamines,
amphetamine derivatives or pyrrolidinophenones. These com-
pounds are often presented under “innocent” appearances (house
scents, herbal mixtures, bath salts, or incenses) and have found a
wide and efﬁcient distribution mechanism through the “e-com-
merce” or specialized shops. These products claim to contain only
“non-illegal” compounds and consequently have no limitations in
their commercial distribution, although they exhibit important
psychoactive effects [2,3]. The purpose of these substances is
mainly to simulate the effects of common drugs of abuse,
Table 1
Selected new psychoactive substances (NPSs), experimental ESI-MS/MS parameters, proposed product ions and predicted log P values.
Target compounda CAS
number
Chemical structure Precursor ion Retention
time (min)
(n¼6)
Internal standard Transition Tube
lens
(V)
Collision
energy
(eV)
Proposed product ions log Pb
1-Naphthyl (1-pentyl-1H-
indol-3-yl) methanone
(JWH-018)
209414-
07-3
ON
[MþH]þ 16.6870.30 JWH-018-d9 3424155 82 25 44
ON
127
155
51
6.51
3424127
1-Naphthyl (1-butyl-1H-
indol-3-yl) methanone
(JWH-073)
208987-
48-8
ON
[MþH]þ 15.9970.25 JWH-018-d9 3284155 76 25 43
ON
127
155
6.07
3284127
(4-Methyl-1-naphthyl)
(1-pentyl-1H-indol-3-
yl) methanone (JWH-
122)
619294-
47-2
O
N
[MþH]þ 17.2270.15 JWH-018-d9 3564169 95 25 38
O
N
141169
7.03
3564141
2-(2-Methoxyphenyl)-1-
(1-pentyl-1H-indol-3-
yl) ethanone(JWH-250)
864445-
43-2
N
O
O
[MþH]þ 15.5570.20 JWH-018-d9 3364121 79 20 35
N
O
O
121
5.30
336491
(4-Ethyl-1-naphthyl)(1- 824959- [MþH]þ 17.4370.25 JWH-018-d9 3704183 96 25 24 7.47
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Table 1 (continued )
Target compounda CAS
number
Chemical structure Precursor ion Retention
time (min)
(n¼6)
Internal standard Transition Tube
lens
(V)
Collision
energy
(eV)
Proposed product ions log Pb
pentyl-1H-indol-3-yl)
methanone (JWH-210)
81-1
O
N
O
N
214
183
3704214
1-Benzylpiperazine (BZP) 2759-28-
6
N
N
[MþH]þ 2.6170.25 BZP-d7 177491 63 28 40
N
N
91, 65 (- C2H2) 1.38
177465
2-(Methylamino)-1-(4-
methylphenyl)-1-pro-
panone (Mephedrone)
1189726-
22-4
N
O [MþH]þ 5.4570.20 Mephedrone-d3 1784160 48 12 19
N
O
160
145
2.12
1784145
1-(4-Methylphenyl)-2-(1-
pyrrolidinyl)-1-propa-
none (MPPP)
13147-
09-6
O
N
[MþH]þ 10.2770.10  2184119 61 24 18
O
N
147
119
2.91
2184147
1-Phenyl-2-(1-pyrrolidi-
nyl)-1-pentanone (a-
PVP)
14530-
33-7
O
N
[MþH]þ 11.6070.20 – 232491 72 27 27
O
N
12691
3.36
2324126
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original drug molecule [3,4]. Consequently, they have similar
pharmacological properties to the popular stimulants
cocaine, amphetamines, 3,4-methylenedioxy-N-methylampheta-
mine (MDMA) or tetrahydrocannabinol (THC) [5–9]. Important
toxicity effects have also been associated with the recreational use
of these drugs [10–14]. The pattern of use and prevalence of NPSs
and their control status are different depending on the country,
but it is clear that both consumption and the number of consumed
substances are increasing fast. This trend can be illustrated
through the rise in notiﬁcations of new substances to the EU early
warning system (EWS), from just 14 in 2005 to 101 in 2014 [15].
Another example can be found in the fact that the number of
monitored synthetic cannabinoids, the largest chemical group of
NPSs, has increased from 30 in 2012 to 134 in 2014 [15].
The information on the use of drugs of abuse and NPSs among
the population can be obtained from self-report data (mainly from
users), questionnaires, police seizures and through chemical ana-
lysis of drug residues in legal and illegal products (herbal, pow-
ders, tablets, paraphernalia), urine, blood, serum and hair samples
[16]. However, highly valuable information can be obtained when
the above epidemiological data is combined with the chemical
analysis of urban wastewater. The estimation and comparison of
community drug use through the analysis of selected drug bio-
markers in sewage is rapidly being established as an effective
monitoring tool [3,17]. Therefore, the development of accurate and
sensitive methodologies for the analysis of NPSs in wastewater is
an urgent need in order to obtain a real picture on the con-
sumption and trends of these substances.
Although there are some approaches to determine qualitatively
(and in some cases quantitatively) NPSs in body samples (blood,
urine or hair, among others) [18], the methodologies for the
quantitative determination of these substances in wastewater are
scarce. Baker and Kasprzyk-Hordern developed a LC-MS/MS multi-
residue method for the analysis of 65 stimulants, including some
NPSs such benzylpiperazine (BZP), included in this study, which
was detected in IWW and EWW from the U.K. with mean con-
centrations of 24.5 and 30.9 ng/L, respectively [19]. It is worth
mentioning that BZP was also detected in river water with a mean
concentration of 26.0 ng/L [19]. A LC-MS/MS based method for
simultaneous determination in wastewater of 14 biomarkers spe-
ciﬁc to synthetic cannabinoids and amphetamine-like substances
was developed by Reid et al. [5]. Three of the 14 analytes were
detected in sewage from Norwegian cities, being the metabolite of
JWH-018, JWH-018N-5-hydroxypentyl, the most ubiquitous, ran-
ging from 63 to 160 ng/L. Mwenesongole et al. used gas chroma-
tography–mass spectrometry (GC–MS) for the analysis in waste-
water of 25 drugs from different classes, including mephedrone
and BZP [20]. In that study, mephedrone was detected in waste-
water from Cambridge (U.K.) at a very high concentration (0.5 mg/
L) while BZP was not detected. Van Nuijs et al. [21] included me-
phedrone for the ﬁrst time in wastewater analysis, although this
substance was not detected in the monitored wastewater treat-
ment plants (WWTPs) of Belgium. Chen et al. [10] determined
mephedrone and BZP in wastewater from Australia using LC-MS/
MS. This study showed that a decline in the MDMA use was as-
sociated with some increases in the use of these compounds, as
well as other synthetic stimulants, in a localized manner.
The present study aims to develop and validate a highly sen-
sitive and efﬁcient methodology based on LC-MS/MS for the
quantitative determination of 10 relevant NPSs from different re-
presentative families in wastewater. The selected compounds are
presented in Table 1. These substances have been detected in
seizures of tablets of synthetic drugs in Greece [22,23]. Moreover
these compounds have been previously detected in human sam-
ples (urine, blood, serum or hair) [24–29]. Some compounds (e.g.
V.L. Borova et al. / Talanta 144 (2015) 592–603596mephedrone and BZP) are controlled according to the Greek leg-
islation but most NPSs, including all the synthetic cannabinoids,
are not [23]. The LC-MS/MS optimization and performance, sample
preparation and method validation were discussed in detail. The
developed methodology was applied to the determination of NPSs
in IWW and EWW of different WWTP of the touristic island of
Santorini (Greece). To the authors’ knowledge, this is the ﬁrst time
that the compounds 4’-methylpyrrolidinobutyrophenone (MPPP),
a-pyrrolidinopentiophenone (a-PVP), and the synthetic cannabi-
noids 2-[(1S,3R)-3-hydroxycyclohexyl]-5-(2-methyl-2-octanyl)
phenol (CP47,497), (1-naphthyl(1-pentyl-1H-indol-3-yl) metha-
none (JWH-018), (1-butyl-1H-indol-3-yl)(1-naphthyl) methanone
(JWH-073), (4-ethyl-1-naphthyl)(1-pentyl-1H-indol-3-yl) metha-
none (JWH-210), (4-methyl-1-naphthyl)(1-pentyl-1H-indol-3-yl)
methanone (JWH-122) and 2-(2-methoxyphenyl)-1-(1-pentyl-1H-
indol-3-yl) ethanone (JWH-250) are investigated in environmental
samples, expanding the knowledge on the occurrence of NPSs in
wastewater, an indicator of the use of these substances in the
community.2. Materials and methods
2.1. Standards and materials
Structures, CAS numbers and predicted log P values of the tar-
get compounds are summarized in Table 1. BZP, the deuterated
standard benzylpiperazine-d7 (BZP-D7), JWH-018, JWH-073, me-
phedrone (2-(methylamino)-1-(4-methylphenyl)-1-propanone)
and mephedrone-d3 were purchased from Cerilliant Corp. (Round
Rock, TX, USA), as certiﬁed solutions. MPPP, a-PVP, JWH-210 and
the deuterated compound JWH-018-d9 were obtained from Cay-
man Chemical Company (East Ellsworth, MI, USA) as certiﬁed so-
lutions and crystallized solids. JWH-122 was purchased from LGC
(Mercatorstrass, Germany), JWH-250 from Toronto Research Che-
micals (Toronto, Canada, USA) and CP 47,497 from THC Pharm
(Frankfurt, Main, Germany) as methanol solution of 98.6% purity.
For the infusion experiments, solutions of individual standards,
including internal standards (IS), were prepared at concentrations
of 1.5 mg/L in methanol (MeOH):Milli-Q water with 0.05% v/v
formic acid (50:50, v/v), just before the experiments. Working
solutions were prepared daily by appropriate dilution of the
mixture stock standard (1.0 mg/L) and IS solutions (1.0 mg/L) in
MeOH. Calibration standards were prepared by serial dilution of
the mixed working solution using Milli-Q water resulting in in-
dividual concentrations ranging from 200 to 80,000 ng/L. All stock
and working solutions were stored in dark glass bottles in the dark
at 20 °C. MeOH, acetonitrile (ACN) and ethyl acetate (EtAc)
(HPLC gradient solvent, 99.9% purity, Lichrosolv) and hydrochloric
acid (37%) were purchased from Merck (Darmstadt, Germany).
High purity water was prepared using a Milli-Q water puriﬁcation
system (Millipore Direct-Q UV, Bedford, MA, USA). Formic acid
(98% purity, HPLC-grade) was obtained from Sigma-Aldrich
(Schweiz, Switzerland). Ammonium hydroxide solution was pre-
pared using ammonia (25%), which was purchased from Panreac
(Barcelona, Spain). Strata-X (200 mg/6 mL) and Strata-XC (200 mg/
6 mL) cartridges and syringe ﬁlters (Phenex RC, 4 mm, pore size
0.2 μm) were obtained from Phenomenex (Torrance, CA, USA).
PolyClean 2H (200 mg/6 mL) and ATOLL XC (200 mg/6 mL) were
purchased from Interchim (Montlucon, France). Lichrolut EN
(200 mg/3 mL), Lichrolut EN (bottom, 100 mg)/RP-18 (top,
200 mg) (6 mL), Lichrolut SCX (200 mg/3 mL) and Lichrolut TSC
(300 mg/3 mL) were obtained from Merck (Darmstadt, Germany).
Additionally, Isolute C18 (EC) (200 mg/6 mL) were obtained from
Biotage (Uppsala, Sweden) and glass ﬁber ﬁlters (GFF, pore size
0.7 μm) used in wastewater ﬁltration were obtained fromMillipore (Cork, Ireland).
2.2. Sampling collection and sample preparation
Samples were obtained from ﬁve wastewater treatment plants
of Santorini Island, a highly touristic Greek island located in the
southern Aegean Sea. Santorini has a population of 15,550 in-
habitants (according with the census of 2011), but it suffers a great
increase of population during summer since it is a very important
touristic center. This touristic island provides a good example to
evaluate the use of NPSs in touristic places where nightlife is also
very popular. For this purpose, IWW and EWW samples (grab
samples) were collected from ﬁve WWTPs in different locations of
Santorini Island. Sampling locations as well as the main char-
acteristics of the WWTPs (all of them equipped with conventional
activated sludge secondary treatment) are described in detail in a
previous study [30]. These samples were collected in July 2013.
Pooled IWW and also pooled EWW samples (separately) were
used for the validation of the method.
In order to estimate the daily variation of the usage of NPSs in
the island, IWW samples (grab samples) were collected from the
WWTP of Fira (the one which serves the largest population) dur-
ing seven consecutive days (from 23/07/2013 to 29/07/2013).
Wastewater samples (both IWW and EWW) were collected in
plastic (PET) bottles, and maintained in the dark under freezing
conditions until their arrival at the laboratory. Next, 50 mL of each
sample were vacuum ﬁltered through a disposable 1000 mL ca-
pacity stericup funnel using GFF (0.7 μm). Once ﬁltered, samples
were acidiﬁed with HCl (1 M) to pH 2.5 (70.1), kept at 4 °C and
extracted within 20 h. No degradation of the compounds was
observed during this storage period.
2.3. Solid phase extraction
Analytes were extracted and preconcentrated from wastewater
samples by solid phase extraction (SPE). SPE experiments were
performed using a VARIAN (Vac Elut SPS 24) manifold and Poly-
Clean 2H (200 mg) cartridges, with spherical pure mixed polymer
sorbent.
In the optimized method cartridges were conditioned with
6 mL of MeOH and 6 mL of acidiﬁed ultrapure water (pH 2.5 with
HCl 1 M). Next, 50 mL of the samples passed through the car-
tridges at a rate of 1 mL/min. Cartridges were washed with 3 mL of
ultrapure water (pH 2.5) at the same ﬂow rate and subsequently
dried under vacuum for 30 min and 10 psi. Analytes were eluted
with 22 mL of MeOH and 42 mL MeOH/EtAc (50:50). The
extracts were evaporated to dryness at 40 °C under a gentle stream
of nitrogen and further reconstituted in 500 μL of MeOH/water
(60:40) followed by 1 min vortex stirring. Finally, the extracts were
ﬁltered through 0.2 μm RC syringe ﬁlters and then transferred to
glass vials for immediate LC-MS/MS analysis.
2.4. LC-tandem mass spectrometry
Instrumental analysis was conducted using an Accela gradient
UHPLC pump equipped with an Accela autosampler system cou-
pled to a TSQ Quantum Access triple-quadrupole mass spectro-
meter, both from Thermo Electron Corporation (Thermo, San Jose,
CA, USA). The triple quadrupole mass spectrometer was equipped
with an electrospray ionization source (Thermo IonMAX). In the
optimized LC method the chromatographic separation of the
compounds was achieved on a Kinetex, pentaﬂuorophenyl (PFP)
reversed-phase fused-core column (50 mm2.10 mm, 1.7 μm)
equipped with a guard PFP column (4 mm20 mm), both from
Phenomenex (Torrance, USA). For the analysis under positive io-
nization mode (PI), the mobile phase was composed by 0.2% v/v
V.L. Borova et al. / Talanta 144 (2015) 592–603 597formic acid in Milli-Q water (A) and MeOH (B) as organic phase.
The adopted elution gradient starts with 40% of MeOH and keeps
constant during 3 min. After that it increases linearly to 100% in
15 min. Pure organic conditions were kept constant for 10 min and
ﬁnally initial conditions were reached and keep constant for 5 min
for column equilibration. The total run time for each injection was
30 min. The column temperature was set to 25 °C. The determi-
nation of CP47,497 was performed under negative ionization mode
(NI), also on the Phenomenex™ Kinetex PFP column. The mobileFig. 1. Comparison of the total Ion Chromatograms (TIC) of new psychoactive sphase was composed by MeOH and ACN. The isocratic program
consists of 90% of MeOH and 10% ACN for 8 min. The mobile phase
ﬂow rate was set to 100 μL/min and the injection volume was
10 μL in both ionization modes.
Identiﬁcation and quantiﬁcation were performed under se-
lected-reaction monitoring (SRM) mode. Two major products ions
of the precursor molecular ion were monitored per analyte. The
most abundant transition was used for quantiﬁcation, whereas the
second most abundant was used for conﬁrmation. Fragmentationubstances using three different stationary phases (concentration: 80 ng/L).
Fig. 2. Optimization of the formic acid concentration in the mobile phase.
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infusion of individual standards of each compound. The used ESI
conditions for both PI and NI mode are reported in detail in a
previous study [30], as they proved to be optimal for the de-
termination of the target analytes, as well.
Chromatographic retention times (tR), SRM transitions, cone
voltages, collision energies and the proposed fragmentation ions
are shown in Table 1. Instrument control and data acquisition and
evaluation were performed using Xcalibur software, version 2.1
(Thermo Electron Corporation).3. Results and discussion
3.1. LC-MS/MS optimization
Three different reversed phase columns, Atlantis T3-C18
(100 mm2.1 mm, 3 μm) and XSelect Τ3-C18 (100 mm2.1 mm,
2.5 μm) from Waters (Milford, MA, USA), and a pentaﬂuorophenyl
(PFP) column (50 mm2.1 mm, 1.7 μm) from Phenomenex, were
compared in terms of chromatographic peak shape and resolution
for the compounds BZP, JWH-073, JWH-018, mephedrone and
MPPP. The synthetic cannabinoids JWH-122, JWH-210 and JWH-
250, with structures and physicochemical properties very similar
to their analogs JWH-073 and JWH-018, as well as the pyrrolidi-
nophenone a-PVP, very similar to MPPP, were further added to the
ﬁnal methodology. Column selection for chromatographic analysis
was an important step since the structures and physicochemical
properties of the different families of compounds are very differ-
ent among them. Atlantis T3 and XSelect T3 have different base
particles (silica particles and high strength silica particles, re-
spectively) and the same ligand (trifunctional alkyl C18), whereas
PFP has a core shell silica and a pentaﬂuorophenyl ligand. All three
columns are appropriate according to the manufacturer for the
analysis of general mixtures containing both polar and non-polar
compounds [31,32]. As it is shown in Fig. 1, the obtained chro-
matograms were very different when using C18 or PFP, due to the
differences among these stationary reverse phases. Stronger re-
tention due to the p–p bonding was observed for the polar com-
pounds when using a PFP column compared to the C18 columns.
On the contrary, the non-polar synthetic cannabinoids were eluted
faster with a PFP column compared to the C18 columns. The dif-
ference in the base particle properties between XSelect and
Atlantis columns resulted in different chromatographic perfor-
mance as can be observed in Fig. 1. Increased retention, higher
resolution and better peak shape for the polar compounds were
achieved with XSelect compared to Atlantis T3, whereas the peak
shape of the non-polar compounds was improved with Atlantis T3.
Nonetheless, both C18 columns presented peak area asymmetry
with a peak fronting effect (particularly relevant for the more
polar compounds) and also lower sensitivity compared with the
PFP column. PFP column was more appropriate for all compounds,
showing better chromatographic performance, especially for polar
compounds containing –NH2 or –NH– groups, providing higher
sensitivity and resolution and more symmetric peaks. Therefore,
PFP column was chosen to perform the experiments.
MeOH and Milli-Q water with formic acid was chosen as mo-
bile phase since this combination showed the best chromato-
graphic performance, when working in PI mode in previous stu-
dies, dealing with psychoactive drugs [30]. Methanol and Milli-Q
water (0.05% v/v formic acid) was used in the experiments for the
column selection. Since the proportion of formic acid in the aqu-
eous phase may play an important role in the peak shape and
particularly in peak intensity [21], this parameter was further
optimized. Different concentrations of formic acid (FA) in Milli-Q
water (0.01% v/v, 0.05% v/v, 0.1% v/v and 0.2% v/v) were tested.These experiments are summarized in Fig. 2, where the total ion
chromatograms of the target compounds are shown with different
FA concentrations. It can be observed how the different FA con-
centration affects retention time, peak shape and peak area (not
shown in Fig. 2) of the analytes. At low concentrations of FA, polar
compounds (BZP, MPPP, a-PVP, mephedrone) showed stronger
retention while at higher FA concentration in the mobile phase
resulted in faster elution, sharper peaks, increased resolution and
enhanced sensitivity. On the contrary, retention time of the non-
polar synthetic cannabinoids remained stable, while peak area and
peak shape were improved signiﬁcantly. A representative example
is MPPP, whose peak area was increased more than 50%, its peak
became sharper, while its retention time decreased by increasing
the concentration of FA. A concentration of 0.2% v/v of formic acid
in the aqueous phase was ﬁnally chosen.
In the NI mode, the best chromatographic conditions were
achieved using MeOH and ACN in isocratic mode without the use
of additional modiﬁer. Column operational temperature was set to
25 °C and was not optimized since previous experiments showed
no signiﬁcantly effects in the chromatographic performance of
similar analytes [30].
Figs. S1 and S2 (supplementary material) show the total ion
chromatograms and the extracted ion chromatograms for the 10
target NPSs analyzed under optimized conditions in both PI and NI
mode. The ﬁnal chromatographic retention times are displayed in
Table 1.
Table 1 also summarizes the optimized values of MS/MS para-
meters for the target compounds. Cone voltage and collision en-
ergies were optimized for every compound through infusion ex-
periments at a concentration of 1.5 mg/L. For all the compounds
determined in Pl mode the precursor ion was [MþH]þ and in the
NI mode the precursor ion corresponded to the deprotonated
molecule [M–H] . Product ions were proposed for all transitions
and are summarized in Table 1. Similar fragmentation pathway
was observed for JWH-018, JWH-122 and JWH-210. For these
compounds the main transition, used for quantiﬁcation, corre-
sponded to the loss of 186 Da ([MþH]þ - [M–C13H16N]þ). In the
case of JWH-250 the quantiﬁcation transition occurred through
the loss of 214 Da ([MþH]þ - [M–C14H16NO]þ) and for JWH-073
through the loss of 172 Da ([MþH]þ - [M–C12H14N]þ).
For the piperazine derivative BZP the quantiﬁcation transition
was formed by the loss of the piperazine group. The ﬁrst transition
of mephedrone was formed by the loss of a water molecule,
whereas the second one occurred by a subsequent loss of –CH3.
MPPP and a-PVP belong to the same group of pyrrolidinophe-
nones, although their fragmentation patterns are different. For
MPPP the ﬁrst transition corresponded to [MþH]þ -
[M–C6H12N]þ and in the case of a-PVP to [MþH]þ -
[M–C8H15NO]þ . CP47,497 is a cyclohexylphenol analog and can be
ionized only under NI mode. Collision induced dissociation frag-
mentation was dominated by the loss of a hydroxyl group. All the
above proposed fragmentation patterns are in agreement with
previous publications [33–35].
3.2. Solid-phase extraction (SPE)
SPE is a critical step and contribute signiﬁcantly to the ﬁnal
performance of the analytical method. SPE was optimized by
evaluating initially six NPSs. Subsequently, four additional com-
pounds with similar structures and physicochemical properties
were added to the ﬁnal methodology, before the validation of the
method was performed.
SPE was optimized through several preliminary experiments
involving the type of sorbent and the elution conditions. Some of
the tested cartridges consisted of strong cation exchange functio-
nalized polymeric sorbents, including Strata-XC (200 mg), ATOLL
Fig. 3. Optimization of the solid phase extraction (SPE) procedure using different sorbents.
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These cartridges were equilibrated with 6 ml of MeOH and 6 ml of
acidiﬁed Milli Q water and the elution of the compounds was
achieved with basic methanol, initially following the procedure
described in detail in a previous publication [30]. The other car-
tridges consisted of polymeric reversed phase and silica based
sorbents including Strata-X (200 mg), PolyClean 2H (200 mg), Li-
chrolut EN (200 mg), Lichrolut EN (bottom, 100 mg)/RP (top,
200 mg) and Isolute C18 (EC) (200 mg). In this case the equili-
bration was performed with 6 ml of methanol and 6 ml of Milli Q
water, whereas the elution was achieved with 6 ml of methanol.
The SPE optimization experiments were performed using a mix-
ture of pooled IWW and EWW samples.
Fig. 3 shows the recoveries obtained with ﬁve different car-
tridges (the results for all the tested cartridges are displayed in
Table S1, in the supplementary material). The cartridges including
strong cation exchange groups (Strata XC and Lichrolut SCX) pro-
vided poor recoveries for all the evaluated compounds, showing
values particularly low for compounds such as mephedrone or
MPPP. However, these cartridges provided very good recoveries for
the cationic compound BZP (with recovery rates up to 88%).
Polymeric cartridges showed relatively good recoveries for all
compounds except for the synthetic cannabinoids. Among these
cartridges, PolyClean 2H was the only one which provided good
results for the polar compound BZP. Although PolyClean 2H pro-
vided very low recoveries for the studied synthetic cannabinoids,
it was chosen for further optimization because of the hypothesis
that this family of compounds was not eluted only with 6 mL of
MeOH and it would be easy to improve the recovery rates by
optimizing the elution step with stronger eluents. Stronger eluents
were also tested with Strata XC cartridges, but, although the re-
coveries of synthetic cannabinoids improved slightly, the re-
coveries for the other compounds remained low. In order to elute
the non-polar synthetic cannabinoids with PolyClean 2H car-
tridges, different combinations of eluents were tested. MeOH was
combined with other solvents, including ACN, dichloromethane,
EtAc and a mixture of MeOH/EtAc (1:1). ACN and dichloromethane
did not improve signiﬁcantly the recoveries. The elution with EtACor with the mixture MeOH/EtAc improved the results for synthetic
cannabinoids, but resulted in lower extraction efﬁciency for other
compounds. The best results were obtained eluting with 4 mL of
MeOH, followed by additional 8 mL of a mixture of MeOH/EtAc 1:1.
Moreover, the results were slightly improved when using acidiﬁed
water (pH 3) during equilibration and washing steps. The values
obtained with the optimized conditions are shown in Fig. 3
(Polyclean 2H improved elution).
Before LC-MS/MS injection, all the samples were ﬁltered
through a 0.2 μm RC syringe ﬁlter for the removal of particles
which may cause blockage of the column ﬁlter and reduce their
life and efﬁciency [30]. RC ﬁlters were previously checked with
standards and it was proved that they do not retain any of the
compounds.
3.3. Quantiﬁcation and method validation
Quantiﬁcation of the target compounds in samples, based on
peak areas, was performed by the internal standardization meth-
od, using spiked samples with the corresponding labeled analyte
(IS). Three deuterated IS were used in order to compensate for
signal suppression or enhancement of the analytes and/or low SPE
recoveries. Table 1 shows the corresponding IS used for each
analyte. The choice of JWH-018-d9 for all the synthetic cannabi-
noids was based on the similar structure and analytical response.
Mephedrone and BZP deuterated internal standards were also
used. Proper labeled standards for compensating the variations of
the compounds a-PVP, MPPP and CP47,497 could not be found.
However, due to their high absolute and reproducible recoveries,
the quantiﬁcation was performed by matrix-matched standards,
without IS. The performance of the method was evaluated under
the optimized conditions in terms of linearity range, detectability,
trueness, accuracy and matrix effects.
The linearity of the method was studied for each compound by
analyzing standard solutions six times at different concentrations,
ranging from 200 to 80,000 ng/L (8 point calibration curve). The
mean correlation coefﬁcients (r2) of the calibration curves pre-
pared in sample diluents were higher than 0.999 and showed good
Table 2
Instrumental quality parameters of the LC-ESI-MS/MS determination of new psy-
choactive substances (NPSs).
Linearity range (ng/L) R2 ILODs (ng/L) ILOQs (ng/L)
JWH-018 200–80,000 0.9994 50 160
JWH-073 200–80,000 0.9991 70 230
JWH-210 200–80,000 0.9995 40 140
JWH-122 200–80,000 0.9992 50 160
JWH-250 200–80,000 0.9996 60 190
Mephedrone 500–80,000 0.9995 180 530
BZP 500–80,000 0.9996 180 530
MPPP 500–80,000 0.9997 200 620
a-PVP 500–80,000 0.9994 200 620
CP47,497 2500–80,000 0.9995 800 2660
V.L. Borova et al. / Talanta 144 (2015) 592–603 601linearity in the range 200–80,000 ng/L or 500–80,000 ng/L for all
the compounds except for CP47,497, which showed a linearity
range from 2500 to 80,000 ng/L (Table 2). Instrumental limits of
detection and instrumental limit of quantiﬁcation (ILOD and ILOQ,
respectively) were determined using diluted standard solutions
(60% MeOH and 40% Milli-Q water with 0.05% v/v formic acid).
ILODs and ILOQs were calculated by dividing the standard devia-
tion of the lowest concentration of standard solvent by the slope of
the calibration curve. These results are summarized in Table 2,
where ILODs ranging from 40 to 800 ng/L (injection 10 μL) can be
observed. The method limits of detection (MLOD) and method
limits of quantiﬁcation (MLOQ) for both IWW and EWW were
calculated by analyzing six times the lowest spiked concentration
(for all of the compounds 10 ng/L) and dividing its standard de-
viation by the slope of the calibration curve of spiked samples. The
deﬁnition of these limits is based on the ability of the method to
distinguish the signal of the analyte from the signal of the noise.
These values are summarized in Table 3. MLOD values ranged from
0.3 to 5 ng/L in efﬂuents for all the compounds except BZP andTable 3
Performance of the LC–ESI-MS/MS method for the determination of new psychoactive s
Concentration le-
vel (ng/L)
Absolute re-
covery (%)
(n¼6)
(7RSD%)
Relative re-
covery (%)
(n¼6)
(7RSD%)
Concentr
vel (ng/L
Inﬂuent
wastewater
JWH-018 10 65 (79) 115 (78) 800
JWH-073 10 60 (79) 106 (79) 800
JWH-210 10 69 (79) 112 (77) 800
JWH-122 10 60 (74) 112 (74) 800
JWH-250 10 54 (710) 101 (78) 800
Mephedrone 10   800
BZP 10   800
MPPP 10 109 (74) – 800
a-PVP 10 96 (72)  800
CP47,497 10   800
Efﬂuent
wastewater
JWH-018 10 44 (78) 121 (77) 800
JWH-073 10 44 (79) 101 (77) 800
JWH-210 10 40 (77) 118 (75) 800
JWH-122 10 40 (79) 106 (78) 800
JWH-250 10 46 (76) 113 (76) 800
Mephedrone 10   800
BZP 10   800
MPPP 10 98 (79)  800
a-PVP 10 98 (74)  800
CP47,497 10   800
Recoveries at the concentration level 10 ng/L have not been calculated for compounds w
internal standard.CP47,497 (MLODs 15 ng/L and 18 ng/L respectively) and from 0.8 to
10 ng/L for all compounds in IWW, with the exception of BZP and
CP47,497, with MLODs of 20 ng/L and 23 ng/L, respectively. True-
ness was assessed with recovery experiments in IWW and EWW
samples. Extraction recoveries for target analytes were de-
termined (n¼6) at two concentration levels, 10 and 800 ng/L in
IWW and EWW. Recoveries were determined by comparing the
concentrations obtained after the whole sample preparation with
the initial spiking levels. As real samples may already contain
target compounds, EWW pool samples and IWW pool samples,
separately, were analyzed in order to determine their concentra-
tions, which were afterwards subtracted from the spiked samples.
Absolute recovery values are summarized in Table 3. Values ran-
ged from 54% to 109% in IWW and from 40% to 102% in EWW for
all compounds. The lowest absolute recoveries were obtained for
the most lipophilic compounds, since their extraction during SPE
was more problematic. However, extraction losses can be well
compensated by the addition of deuterated IS as indicated by re-
lative recoveries values summarized in Table 3. Relative recovery
values are close to 100% for all compounds. Overall method intra-
day precision was evaluated in IWW and EWW as relative stan-
dard deviation (RSD %) by spiking wastewater samples with 10 and
800 ng/L of each compound (n¼6). For both concentration levels
and matrixes, RSD values were below 13% for all the compounds.
These values were also improved with the use of IS (Table 3). The
extent of matrix effects was evaluated during analysis. Matrix ef-
fects were assessed by dividing the response of the analytes in
matrix-matched standards by the response in pure standard so-
lution. Three different EWW and three IWW were tested. The
obtained values (average) are shown in Table 3. For all the analytes
in both matrixes, signal suppression was observed. It ranged from
19% to 50% in EWW. Higher suppression was observed in IWW
with values ranging from 23% to 85%.ubstances in wastewater samples.
ation le-
)
Absolute re-
covery (%) (n¼6)
(7RSD%)
Relative re-
covery (%)
(n¼6)
(7RSD%)
ME (%) MLODs
(ng/L)
MLOQs
(ng/L)
65 (710) 114 (78) 54 0.8 2.4
61 (79) 110 (78) 61 1.4 4.1
73 (711) 109 (79) 23 1.1 3.2
67 (710) 103 (710) 45 1.4 4.4
69 (79) 116 (79) 64 1.4 4.4
95 (76) 101 (75) 63 10 33
61 (79) 104 (75) 85 20 67
97 (77)  60 3.0 10
103 (78)  59 1.9 6.3
99 (76)  42 23 77
50 (76) 85 (75) 45 0.7 2.0
51 (75) 99 (74) 32 1.2 3.8
51 (79) 82 (77) 33 0.5 1.5
57 (79) 89 (78) 50 0.3 0.9
61 (78) 107 (76) 23 0.5 1.6
99 (76) 110 (74) 35 5.0 17
58 (713) 86(79) 43 15 50
98 (711) – 19 1.5 5.0
102 (78)  25 1.5 5.0
91 (710)  20 18 60
ith MLOQ410. Relative recoveries have not been calculated for compounds with no
Table 4
Concentrations of new psychoactive substances in wastewater samples (ng/L) of ﬁve wastewater treatment plants (WWTPs) located in different areas of Santorini Island
(Greece).
JWH-018 JWH-073 JWH-210 JWH-122 JWH-250 Mephedrone BZP MPPP a-PVP CP47, 497
Inﬂuent wastewater
Kamari n.d. n.d. 3.7 oLOQ n.d. n.d. n.d. n.d. 6.5 79
Fira n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. oLOQ oLOQ
Karterados n.d. n.d. n.d. oLOQ n.d. n.d. n.d. n.d. oLOQ 130
Emporio n.d. n.d. oLOQ oLOQ n.d. n.d. n.d. n.d. n.d. 305
Ia n.d. n.d. n.d. n.d n.d. n.d. n.d. n.d. n.d. oLOQ
Efﬂuent wastewater
Kamari n.d. n.d. 2.7 2.8 n.d. n.d. n.d. n.d. n.d. 60
Fira n.d. n.d. 1.9 1.6 n.d. n.d. n.d. n.d. n.d. 223
Karterados n.d. n.d. 2.4 4.1 n.d. n.d. n.d. n.d. n.d. 74
Emporio n.d. n.d. 1.5 1.5 n.d. n.d. n.d. n.d. n.d. 176
Ia n.d. n.d. oLOQ n.d. n.d. n.d. n.d. n.d. n.d. 78
n.d.: not detected; oLOQ: below method limit of quantiﬁcation.
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To demonstrate the suitability of the developed multi-residue
methodology, the occurrence of the selected NPSs was evaluated
in IWW and EWW grab samples of ﬁve different WWTP in San-
torini Island, and also in grab IWW samples from Fira during seven
different days, as described in Section 2.2.
Four out of the 10 evaluated NPSs were detected in at least one
of the wastewater samples. Table 4 summarizes the concentrations
values of the target compounds obtained in the grab samples of
the ﬁve different WWTPs. The synthetic cannabinoids JWH-018,
JWH-073 and JWH-250 were not detected either in IWW or EWW.
The compounds JWH-210 and JWH-122 were detected in IWW
and EWW at low levels, in the range oLOQ–4.1 ng/L. These low
levels can be explained by the fact that synthetic cannabinoids
undergo extensive metabolism within the body, leading to low
levels of the parent compound present in urine [4]. Mephedrone,
BZP and MPPP were also not detected in any sample while the
pyrrolidinophenone a-PVP was detected in three IWW samples in
the range 1.5–6.5 ng/L. CP47,497 was the compound detected at
highest levels, from 60 up to 305 ng/L, suggesting an important
consumption of this substance. It is noteworthy that in some cases
higher concentrations of CP47,497 were determined in EWW. This
fact can be explained by the formation of unmeasured products of
phase II human metabolism and/or transformation products (e.g.
glucuronide conjugate, sulfates, glycinates) that during the was-
tewater treatment they hydrolyzed back to the parent compounds.
Nevertheless, it is important to consider that the analyzed samples
were grab samples and do not provide directly comparable results
as can be obtained by analyzing composite samples.
The results of the evaluation of the occurrence of NPSs in IWW
from Fira, the main city of Santorini Island, during seven con-
secutive days are displayed in Table S2 (this sampling was con-
ducted on different dates that the results shown in Table 4). The
synthetic cannabinoids JWH-018, JWH-073 and JWH-250 were not
detected in any sample, while JWH-210 and JWH-122 were de-
tected in two and one sample, respectively, at low concentrations
(below MLOQs and 4.5 ng/L). These results are in agreement with
those obtained for the grab samples described in Table 4. On the
contrary, a-PVP was not detected in any sample. MPPP and the
stimulant mephedrone (which was detected at low levels in
Cambridgeshire (U.K.) in a previous study [36]) were also not de-
tected. BZP remained undetected, in contrast with high fre-
quencies of detection determined in previous reports carried out
in the U.K. [19,37]. High levels found for CP47,497 (89–634 ng/L)
are notable, with high differences among the evaluated days. Re-
sults for this compound did not show a clear trend of use duringthe evaluated period, but showed a high use of this substance.
Differences in the concentration ranges between the two different
monitoring studies can be explained by the fact that the samples
consisted of grab samples. Although the results do not allow ﬁrm
conclusions, a constant use of some of the determined NPSs, such
as CP47,497, was clearly observed. This compound is present in
different herbal mixtures (e.g. Spice) and other products (bath
salts or incense) and it is frequently mixed with other synthetic
cannabinoids [38]. Currently no legislation exists regarding this
substance in Greece.4. Conclusions
An analytical method for the simultaneous determination of 10
NPSs, based on SPE cleanup and LC-MS/MS analysis, was devel-
oped, optimized and validated for the determination of these
compounds in IWW and EWW.
Factors such as the selection of the chromatographic column or
the performance of the SPE cleanup were studied in detail. The use
of PolyClean 2H SPE cartridges and a PFP column provided the best
method performance. Despite the difﬁculties due to the wide
range of physicochemical properties of the target analytes, the
developed methodology is efﬁcient, accurate and allows a reliable
determination of the selected NPSs in the low ng/L level, being
suitable to perform monitoring studies of the target analytes in
wastewater samples.
The proposed methodology was successfully applied for the
determination of NPSs in IWW and EWW samples from several
WWTPs in Santorini Island (Greece), where four out of the 10
selected analytes were detected at least in one sample, showing a
relevant use of these substances in the studied areas. Eight of the
10 target analytes were investigated in wastewater for the ﬁrst
time and the compounds a-PVP, CP47,497, JWH-122 and JWH-210
were detected for the ﬁrst time in inﬂuents and efﬂuents.
These results also conﬁrm that the analysis of NPSs in waste-
water is a powerful tool that can provide valuable information on
patterns of use of these substances. There is a need of developing
new analytical methodologies with higher number of NPSs in or-
der to obtain the whole picture of the use of drugs of abuse.Acknowledgments
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